Delving into the Latest Updates on FMP-010 vaccine(Walter Reed Army Institute of Research) with Synapse

Overview

Drug Type

Therapeutic vaccine, Genetically engineered subunit vaccine

Synonyms

FMP 010 vaccine, FMP010/AS01B

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Active Indication-

Inactive Indication

Originator Organization

Active Organization-

Inactive Organization

License Organization-

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Malaria	Phase 1	-	GSK Plc	01 Apr 2008
Malaria	Phase 1	-	Walter Reed Army Institute of Research	01 Apr 2008
Malaria, Falciparum	Phase 1	United States	GSK Plc	01 Apr 2008
Malaria, Falciparum	Phase 1	United States	Walter Reed Army Institute of Research	01 Apr 2008
Malaria, Falciparum	Phase 1	Kenya	Walter Reed Army Institute of Research	01 Apr 2008
Malaria, Falciparum	Phase 1	Kenya	GSK Plc	01 Apr 2008

Login to view more data

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


NCT02458092 (CTgov)	Phase 1	Malaria	30	Rabipur (Rabies Vaccine Rabipur)	kkdsasccjp = buuggtptxq ecpxglgoet (ogmzxmcitp, acjwrzwfux - utswnpalbu) View more	-	09 Jun 2020
				Plasmodium falciparum Malaria Protein 010 (FMP010) (50 µg of FMP010 Antigen in 0.5 mL AS01B Adjuvant)	gsrkyvvotw(bkhzdsaxsu) = przecmrxpp fqtacctedu (cufadlqvqr, rxuengqpgb - hztdvqptbb) View more